13-M(Serca Pharmaceuticals AS)

N/A

Report date: 2023/09/22 17:39:32
NME

Base Information

Drug Name13-M(Serca Pharmaceuticals AS)
Drug Alias Name13-M
ClassificationSmall molecules
Mechanisms of ActionSarcoplasmic/endoplasmic reticulum calcium ATPase 2 inhibitors
TargetsSarcoplasmic/endoplasmic reticulum calcium ATPase 2
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A